Search results

Order by most recent / most popular / relevance

Results: 1-10 of 59

Biovail v. Apotex; merits of 55.2 proceeding; metformin

Gowling Lafleur Henderson LLP
-
Canada
-
February 12 2010

The Court dismissed the application for prohibition

Apotex v. Sanofi; interlocutory motion re: affidavits of documents; clopidogrel

Gowling Lafleur Henderson LLP
-
Canada
-
February 12 2010

Both parties brought motions for further and better affidavits of documents

AstraZeneca v. Apotex; interlocutory motion for reply evidence; esomeprazole

Gowling Lafleur Henderson LLP
-
Canada
-
February 12 2010

The Court dismissed AstraZeneca's appeal from the order of a prothonotary refusing to strike parts of Apotex' evidence and refusing to permit the applicants to file reply

Janssen-Ortho v. Apotex; interlocutory motion for reply evidence; methylphenidate

Gowling Lafleur Henderson LLP
-
Canada
-
February 12 2010

In two NOC proceedings, the order of evidence was reversed

Epicept v. Minister of Health; interlocutory motion for confidentiality; histamine

Gowling Lafleur Henderson LLP
-
Canada
-
February 12 2010

Epicept has filed for a judicial review of the Minister's decision that its histamine dihydrochloride product is not an innovative drug and is thus not eligible for listing on the register of innovative drugs

Janssen-Ortho v. Novopharm; merits of 55.2 proceeding; methylphenidate

Gowling Lafleur Henderson LLP
-
Canada
-
February 12 2010

The only issue in this proceeding was an allegation of non-infringement and the application for prohibition was dismissed

Mycogen v. Bayer and Monsanto; motion for summary judgment

Gowling Lafleur Henderson LLP
-
Canada
-
February 12 2010

Bayer brought a motion for summary judgment on the basis that Monsanto had missed the time set out by the Commissioner under section 43 of the Patent Act to respond to the conflict proceeding

Canada (Attorney General) v. Celgene Corporation, appeal of a PMPRB decision

Gowling Lafleur Henderson LLP
-
Canada
-
January 20 2010

The Court of Appeal overturned the decision of the Trial Judge and restored the decision of the PMPRB providing jurisdiction to the PMPRB over medicines imported under the Special Access Program

Eli Lilly v. Hospira, interlocutory motion regarding further and better affidavit of documents

Gowling Lafleur Henderson LLP
-
Canada
-
January 20 2010

In a case of patent infringement, the Case Management Prothonotary had ordered Hospira to produce a further and better Affidavit of Documents pursuant to an earlier motion by the Plaintiffs

Sanofi-Aventis v. ApotexNovopharmRiva, interlocutory motion to consolidate actions

Gowling Lafleur Henderson LLP
-
Canada
-
January 20 2010

Sanofi brought a motion to consolidate three actions pertaining to damages pursuant to section 8 of the NOC Regulations

next >